Development
Johnson & Johnson
JNJ
$155.03
$1.370.89%
NYSE
| 12/31/2023 | 10/01/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 0.21% | 20.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.21% | 20.85% | |||
| Cost of Revenue | 5.25% | 28.78% | |||
| Gross Profit | -1.94% | 17.76% | |||
| SG&A Expenses | 7.19% | 34.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 11.62% | 20.84% | |||
| Operating Income | -26.34% | 20.88% | |||
| Income Before Tax | -7.49% | -9.36% | |||
| Income Tax Expenses | -23.57% | 13.08% | |||
| Earnings from Continuing Operations | -4.11% | -13.00% | |||
| Earnings from Discontinued Operations | -100.38% | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -84.44% | 405.99% | |||
| EBIT | -26.34% | 20.88% | |||
| EBITDA | -24.97% | 13.86% | |||
| EPS Basic | -85.81% | 421.86% | |||
| Normalized Basic EPS | -35.88% | 5.71% | |||
| EPS Diluted | -85.69% | 421.28% | |||
| Normalized Diluted EPS | -35.20% | 7.08% | |||
| Average Basic Shares Outstanding | 9.66% | -3.04% | |||
| Average Diluted Shares Outstanding | 8.51% | -3.06% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -- | -- | |||